Regorafenib
Product Description
CLEARSYNTH LABS LIMITED
-
IN
-
2015On CPHI since
-
2Certificates
-
250 - 499Employees
Company types
Primary activities
Specifications
CLEARSYNTH LABS LIMITED
-
IN
-
2015On CPHI since
-
2Certificates
-
250 - 499Employees
Company types
Primary activities
More Products from CLEARSYNTH LABS LIMITED (99)
-
Product Clobetasol D5
Labelled Clobetasol. Topical corticosteroid. Glucocorticoid; anti-inflammatory.;Labeled Clobetasol, intended for use as an internal standard for the quantification of Clobetasol by GC- or LC-mass spectrometry. -
Product Ethopabate
A supplementary drug that improves the coccidiostatic effect of nicarbazin and amprolium in order to cure coccidiosis in chickens. -
Product Sirolimus (Rapamycin)
An immunosuppressant macrolide antibiotic and an inhibitor of FRAP. -
Product Celacol M 20
Methylcellulose is used as a preservative, thickener and emulsifier in various food and cosmetic substances. -
Product Clindamycin 13C D3 Hydrochloride
Labeled Clindamycin, intended for use as an internal standard for the quantification of Clindamycin by GC- or LC-mass spectrometry. -
Product Clopidogrel D4 Hydrogen sulfate
Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry. -
Product Sapropterin
Sapropterin is a Phenylalanine Hydroxylase Activator. -
Product Clopidogrel D3 Hydrochloride
Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry. -
Product Clopidogrel D3 Hydrogen sulphate
Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry. -
Product Diazepam Impurity F (BP)
Impurity in commercial preparations of Diazepam -
Product Doxofylline
Doxofylline is a xanthine molecule that appears to be both bronchodilator and anti-inflammatory with an improved therapeutic window over conventional xanthines such as Theophylline and the evidence supporting the effects of Doxofylline in the treatment -
Product Rasagiline
Rasagiline, is a selective and irreversible propargylamine inhibitor of monoamine oxidase which has been used to increase the availability of dopamine at striatal receptors as a method to treat Parkinson’s disease.
CLEARSYNTH LABS LIMITED resources (1)
-
Brochure Corporate Profile
Your Globally ''Trusted'' Partner for Reference Standards and Research Chemicals.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance